Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.23 USD
Change Today -0.0049 / -2.09%
Volume 2.1M
HEB On Other Exchanges
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - hemispherx biopharma inc (HEB)

NameBoard RelationshipsTitleAge
William A. Carter M.D.6 RelationshipsChairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee76
Thomas K. Equels Esq.6 RelationshipsExecutive Vice Chairman, Chief Financial Officer, General Counsel, Secretary, Director, Member of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee62
Wayne S. Springate No RelationshipsSenior Vice President of Operations43
David R. Strayer M.D.No RelationshipsChief Medical Officer and Medical Director68

Board Members - hemispherx biopharma inc (HEB)

NameBoard RelationshipsPrimary CompanyAge
William A. Carter M.D.6 RelationshipsHemispherx Biopharma, Inc.76
Thomas K. Equels Esq.6 RelationshipsHemispherx Biopharma, Inc.62
William M. Mitchell M.D., Ph.D.12 RelationshipsHemispherx Biopharma, Inc.79
Iraj Eqhbal Kiani MBA, N.D., Ph.D.6 RelationshipsHemispherx Biopharma, Inc.68
Peter W. Rodino III, Esq.6 RelationshipsHemispherx Biopharma, Inc.63

Executive Committees* - hemispherx biopharma inc (HEB)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteePeter W. Rodino III, Esq. 6 Relationships3 Executives
Compensation CommitteeIraj Eqhbal Kiani MBA, N.D., Ph.D. 6 Relationships3 Executives
Nominating CommitteeWilliam M. Mitchell M.D., Ph.D. 12 Relationships3 Executives
Corporate Governance CommitteeWilliam M. Mitchell M.D., Ph.D. 12 Relationships3 Executives
Executive CommitteeWilliam A. Carter M.D. 6 Relationships3 Executives
View HEB Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.23 USD -0.0049

HEB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $301.35 USD +0.13
AstraZeneca PLC 4,474 GBp +48.50
Baxter International Inc $67.37 USD -0.17
Medigene AG €8.50 EUR -0.459
Sarepta Therapeutics Inc $26.22 USD +1.96
View Industry Companies

Industry Analysis


Industry Average

Valuation HEB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 313.0x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 232.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at